Pacira BioSciences announces positive topline data from phase 3 study of Exparel as a single-dose sciatic nerve block in the popliteal fossa for bunionectomy. News release. Pacira BioSciences, Inc ...

– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Significantly greater proportion of opioid-free patients receiving ...

References: Pacira announces FDA approval of expanded Exparel label to include two additional nerve block indications. News release. Pacira BioSciences, Inc. November 10, 2023.

Peripheral nerve blocks are effective for postoperative analgesia after total knee replacement surgery. However, in some cases, problems can arise to delay the rehabilitation of the patient.

VANCOUVER, British Columbia — Recent research indicates that using ultrasound guidance for the placement of sciatic nerve block injections at the popliteal fossa is effective. “Ultrasound ...

FDA expands indications for bupivacaine liposome injectable suspension (Exparel; Pacira BioSciences, Inc.) for use in adult patients as an adductor canal block and a sciatic nerve block in the ...

PCRX has put up a strong performance in six months with shares rallying 66.8%. However, its sole dependence on Exparel for growth is a concern. We advise investors to wait for now.

The authors evaluated the effects of locally anesthetizing the sciatic and femoral nerves in sheep undergoing stifle (femorotibial) surgery (16 sheep received nerve blocks; 16 sheep underwent a ...

Results showed the addition of a single-injection proximal sciatic nerve block to an adductor canal block significantly reduced pain and opioid requirements in pediatric patients undergoing medial ...

— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an ...

Ultrasound guided pudendal nerve block: A cadaveric study Date: March 6, 2014 Source: American Academy of Pain Medicine (AAPM) Summary: The spread of close to 80% of injectate to surrounding soft ...

TAMPA, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions ...